Skip to main content
OpenTrials
Completed

NCT Number: NCT04876898

High Body Mass Index and Severity of Coronavirus

A cohort study included 114 adult patients with confirmed COVID-19 were categorized by BMI levels on admission: overweight (25-29.9 kg/m2), and obesity (four categories: 30-34.9 kg/m2, 35-39.9 kg/m2, 40-44.9 kg/m2, and ≥45 kg/m2).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COVID-19 Pneumonia

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Gad sayed Gad

Qina, Qena Governorate, 83511, Egypt

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients older than 18 years
  • confirmed COVUID 19 infection
  • body mass index more than 25kg/m2

Exclusion criteria

-

Treatment and study plan

prospective cohort in high body mass index patient with covid 19

Other

A cohort study included 114 adult patients with confirmed COVID-19 were categorized by BMI levels

Primary outcomes

  1. pneumonia

    Time frame: 30 days

    patients percentages

  2. sever pneumonia

    Time frame: 30 days

    patients percentages

  3. ICU admission

    Time frame: 30 days

    patients percentages

Secondary outcomes

  1. length of hospital stay

    Time frame: 30 days

    days

  2. clinical complication

    Time frame: 30 days

    patients percentages

Sponsors and collaborators

Lead sponsor

South Valley University

Other

Registry information

Official study title

High Body Mass Index and Severity of Coronavirus Disease 2019 (Covid-19): a Cohort Study

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
May 7, 2021
Registry last updated
May 7, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.